Tonix Pharmaceuticals Holding Corp. (TNXP) stock
TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3083% below fair value
$2.94+0.06 (+2.08%)
Close on Nov 17, 2026Market cap $50.42MP/E –Yield –
Tonix Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Tonix Pharmaceuticals's total assets was $254.09M at Jun 30, 2026. For fiscal 2025 it was $277.17M, up 70.2% from the year before. Over ten years it grew 19.4% a year on average. The highest annual figure on record is $277.17M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $277.17M | +70.2% |
| FY2024 | Dec 31, 2024 | $162.89M | +5.5% |
| FY2023 | Dec 31, 2023 | $154.46M | -31.6% |
| FY2022 | Dec 31, 2022 | $225.69M | -6.3% |
| FY2021 | Dec 31, 2021 | $240.90M | +145.4% |
| FY2020 | Dec 31, 2020 | $98.18M | +574.4% |
| FY2019 | Dec 31, 2019 | $14.56M | -44.7% |
| FY2018 | Dec 31, 2018 | $26.32M | -1.6% |
| FY2017 | Dec 31, 2017 | $26.75M | -2.7% |
| FY2016 | Dec 31, 2016 | $27.51M | -41.5% |
| FY2015 | Dec 31, 2015 | $47.02M | +18.9% |
| FY2014 | Dec 31, 2014 | $39.54M | +352.6% |
| FY2013 | Dec 31, 2013 | $8.74M | +312.7% |
| FY2012 | Dec 31, 2012 | $2.12M | +397.6% |
| FY2011 | Dec 31, 2011 | $425.45K | +131.2% |
| FY2010 | Dec 31, 2010 | $184.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $254.09M | +35.6% |
| Q1 FY2026 | Mar 31, 2026 | $257.91M | +33.7% |
| Q4 FY2025 | Dec 31, 2025 | $277.17M | +70.2% |
| Q3 FY2025 | Sep 30, 2025 | $252.44M | +165.8% |
| Q2 FY2025 | Jun 30, 2025 | $187.36M | +166.5% |
| Q1 FY2025 | Mar 31, 2025 | $192.87M | +42.5% |
| Q4 FY2024 | Dec 31, 2024 | $162.89M | +5.5% |
| Q3 FY2024 | Sep 30, 2024 | $94.99M | -31.8% |
| Q2 FY2024 | Jun 30, 2024 | $70.31M | -56.0% |
| Q1 FY2024 | Mar 31, 2024 | $135.34M | -24.4% |
| Q4 FY2023 | Dec 31, 2023 | $154.46M | -31.6% |
| Q3 FY2023 | Sep 30, 2023 | $139.28M | -42.6% |
| Q2 FY2023 | Jun 30, 2023 | $159.74M | -42.2% |
| Q1 FY2023 | Mar 31, 2023 | $179.09M | -19.9% |
| Q4 FY2022 | Dec 31, 2022 | $225.69M | -6.3% |
| Q3 FY2022 | Sep 30, 2022 | $242.65M | +13.0% |
| Q2 FY2022 | Jun 30, 2022 | $276.17M | +46.0% |
| Q1 FY2022 | Mar 31, 2022 | $223.72M | +21.9% |
| Q4 FY2021 | Dec 31, 2021 | $240.90M | +145.4% |
| Q3 FY2021 | Sep 30, 2021 | $214.77M | +217.6% |
| Q2 FY2021 | Jun 30, 2021 | $189.17M | +224.2% |
| Q1 FY2021 | Mar 31, 2021 | $183.52M | +440.8% |
| Q4 FY2020 | Dec 31, 2020 | $98.18M | +574.4% |
| Q3 FY2020 | Sep 30, 2020 | $67.62M | +451.0% |
| Q2 FY2020 | Jun 30, 2020 | $58.35M | +288.8% |
| Q1 FY2020 | Mar 31, 2020 | $33.93M | +69.5% |
| Q4 FY2019 | Dec 31, 2019 | $14.56M | -44.7% |
| Q3 FY2019 | Sep 30, 2019 | $12.27M | -23.6% |
| Q2 FY2019 | Jun 30, 2019 | $15.01M | -18.2% |
| Q1 FY2019 | Mar 31, 2019 | $20.02M | -4.6% |
| Q4 FY2018 | Dec 31, 2018 | $26.32M | -1.6% |
| Q3 FY2018 | Sep 30, 2018 | $16.06M | -47.4% |
| Q2 FY2018 | Jun 30, 2018 | $18.36M | -48.8% |
| Q1 FY2018 | Mar 31, 2018 | $20.98M | -11.8% |
| Q4 FY2017 | Dec 31, 2017 | $26.75M | -2.7% |
| Q3 FY2017 | Sep 30, 2017 | $30.54M | +2.5% |
| Q2 FY2017 | Jun 30, 2017 | $35.82M | – |
| Q1 FY2017 | Mar 31, 2017 | $23.78M | – |
| Q4 FY2016 | Dec 31, 2016 | $27.51M | – |
| Q3 FY2016 | Sep 30, 2016 | $29.80M | – |
See a number that looks wrong?